张志斌与郑国锐是乐普医疗崛起过程中当之无愧的老将，是从基层一步步走上高管岗位的励志故事主角。Tonight, Lepu Medical Technology announced that General Manager Zhang Zhibin and Deputy General Manager Zheng Guorui resigned, and the chairman's daughter, Pu Fei, took over as the general manager, who has a background of "sea turtle elite". Starting in 2023, Lepu Medical Technology's performance has seen consecutive quarters of decline, with the market cap falling by a quarter compared to its peak.
Finance Associated Press on September 25th (Reporter Lu Afeng) In the situation of consecutive quarters of declining revenue and net profit, Lepu Medical Technology (300003.SZ) has chosen a 'second generation successor', whether it can reverse the declining performance has become the most severe test at present.
On the 25th, Lepu Medical Technology announced that the company's Board of Directors recently received resignation reports from the company's General Manager Zhang Zhibin and Deputy General Manager Zheng Guorui, who applied to resign from their current positions due to personal reasons and will no longer hold any positions in the company. In addition, nominated by the chairman of the board, the board of directors approved the "Proposal on Appointing the Company's General Manager", agreeing to appoint Ms. Pu Fei as the company's general manager.
Zhang Zhibin and Zheng Guorui have been worthy veterans in the rise of Lepu Medical Technology, protagonists of inspirational stories who rose from the grassroots to executive positions.
According to Tianyancha and relevant announcements from Lepu Medical Technology, Zhang Zhibin was born in 1976 and has served as the sales manager of Lepu Medical Technology's Northwest/Beijing region, General Manager of Shanghai Shape Memory Alloy Materials Co., Ltd., Director of Lepu Medical Technology's Marketing Department, and Deputy General Manager of Lepu Medical Technology; Zheng Guorui was born in 1982 and has served as the sales manager of Wuhan Yuanda Pharmaceutical Co., Ltd., Lepu Medical Technology's sales manager, Lepu Pharmaceutical Market Director, National Sales Director, and Assistant General Manager of Lepu Medical Technology.
In the position of General Manager at Lepu Medical Technology, Zhang Zhibin has worked for 9 years, while Zheng Guorui has worked as Deputy General Manager for 3 years. As of today, Zhang Zhibin holds 0.2175 million shares of the company, accounting for 0.0116% of the total share capital. Zheng Guorui holds 0.03 million shares of the company, accounting for 0.0016% of the total share capital.
As the successor, Pu Fei is the daughter of Lepu Medical Technology's Chairman Pu Zhongjie, and she has a clear "sea turtle" elite background, with professional experience in finance and the medical industry.
According to Tianyancha, Pu Fei, born in 1989, holds dual degrees in Materials Engineering and Management Finance from the Massachusetts Institute of Technology (MIT), and a Master's degree in Applied Physics from Harvard University. She has previously worked as an internship analyst at Credit Suisse Bank in Hong Kong, 3M USA as a material research and development engineer, and as a co-founder of Ningbo Future Power Education Co., Ltd.
Since 2017, Pufei successively served as the manager of the international trade department of Lepu Medical Technology, the director of the international business department of Lepu Medical Technology, a director of Lepu Medical Technology, and a supervisor of Lepu Medical Technology.
The recent changes in senior management at Lepu Medical Technology may be somewhat related to its declining performance.
Starting in 2023, Lepu Medical Technology's revenue and performance began to show a declining trend. In the first half of 2023, Lepu Medical Technology's revenue decreased by 19.35% year-on-year, and net profit attributable to the parent company decreased by 24.17%; in 2023, Lepu Medical Technology's revenue decreased by 24.78% year-on-year, and net profit attributable to the parent company decreased by 42.91%; in the first half of 2024, Lepu Medical Technology's revenue decreased by 21.33% year-on-year, and net profit attributable to the parent company decreased by 27.48%.
In terms of market cap, Lepu Medical Technology's stock price peaked in 2020 at 45.64 yuan per share, with a market cap exceeding 80 billion. Subsequently, Lepu Medical Technology's stock price began to oscillate downwards, with the stock price as of today at 9.73 yuan per share, and a market cap of 18.3 billion yuan, only a quarter of its peak period.
